22 March 2018

Several newspapers, including Algemeen Dagblad, Brabants Dagblad and De Gelderlander, opened on 15 March with articles about the research results concerning the long-term effects of Q fever. The NOS paid attention to this research on Radio 1 and in the national television news, just like Hart van Nederland and EenVandaag.

Researcher and epidemiologist Ellen van Jaarsveld of the department of Primary and Community Care, was also guest at the news bulletin of Omroep Brabant. The widespread media attention led, among other things, to the fact that the research was also discussed in the House of Representatives. Ellen investigated the long-term effects of 2600 Q fever patients with several colleagues from the academic workshop AMPHI (infectious diseases). Especially patients with chronic Q fever experience an increase in symptoms over the years, says Ellen. Fatigue increases and quality of life decreases. In patients with Q Fever Fatigue Syndrome (QVS), the study shows, that patients up to 8 years after acute Q fever infection continue to have many complaints and physical limitations. The results of the research were presented on 15 March in Eindhoven during the final conference of Q-support, the foundation for patients with Q Fever.
 
https://www.ad.nl/binnenland/onderzoek-naar-q-koorts-ondanks-behandeling-worden-klachten-alleen-maar-erger~a833e156/
https://eenvandaag.avrotros.nl/item/nieuw-onderzoek-klachten-van-q-koortspatienten-worden-erger/

 

Related news items


Vici grant for Michiel Vermeulen Reading the epitranscriptome

15 April 2021

Michiel Vermeulen, theme Cancer development and immune defense, has been awarded a Vici grant from the Netherlands Organisation for Scientific Research (NWO), one of the largest personal scientific awards in the Netherlands.

read more

2.5 million Euros for cancer research into ovarian cancer and immunotherapy

15 April 2021

The Radboudumc receives 2.5 million Euros from the Dutch Cancer Society (KWF) for three studies to ensure oncological progress during COVID-19 period.

read more

Miljoenen voor kennis- en investeringsconsortium op het gebied van AI

14 April 2021

Een kennis- en investeringsconsortium met het Radboudumc heeft acht miljoen euro subsidie gekregen om innovatie op het gebied van Artificial Intelligence (AI) versneld naar de markt te brengen.

read more

Genetische pleister ‘remt’ blindheid in patiënten met Usher syndroom Leidse ProQR bouwt onderzoek Radboudumc verder uit

14 April 2021

Het Leidse biotechbedrijf ProQR Therapeutics presenteerde deze week positieve resultaten van een klinische fase I/II studie met het molecuul QR-421a, een molecuul dat in de vroegste fase is ontwikkeld door onderzoekers van het Radboudumc

read more

Freezer Challenge by Teun Bousema

13 April 2021

13 research groups, 1280 boxes discarded, 26% less energy consumption, and two winners. Watch our short video with the results of the Radboud Freezer Challenge. It is safe, and you can do it anytime. Warm up your freezers to cool down the planet!

read more

Current overview of intriguing RNA therapies

8 April 2021

In an article in EMBO Molecular Medicine, researchers from Radboudumc, together with European colleagues, provide an up-to-date overview of the (im)possibilities of these intriguing RNA therapies.

read more